Chinese scientists have introduced 508 volunteers experimental vaccine against the coronavirus SARS-CoV-2. This publication reports the Global Times.
the First stage of clinical trials was held from 16 March and has been completed. While she had checked the safety of the vaccine. April 12 began the second phase, designed to confirm its effectiveness. If all goes according to plan, in may will occur the so-called disclosure of the code: participants in the study will know which treatment patients received.
Chinese scientists have developed a recombinant vaccine based on adenovirus vector, using the successful experience accumulated when working on a vaccine against the Ebola virus. According to epidemiologist Chen Wei from the Beijing Military medical Academy, which manages the research, data obtained at the seventh and 14th day after injection, showed that the vaccine is safe.
Group Chen Wei first moved to the second phase of clinical trials ahead of other researchers in China and other countries developing a vaccine against the new coronavirus infection. “At the moment, the vaccine could become one of the most powerful tools for suppressing the coronavirus,” said Chen Wei.
In March, it was reported that volunteers participating in trials of this vaccine were divided into three groups, which will introduce the different doses of the drug. After vaccination they will spend in quarantine 14 days, and then within six months will pass regular medical examinations. The research will continue until December 31.
According to the latest data, April 25 in the world, discovered of 2.85 million cases of infection with novel coronavirus infection. From COVID-19 died 197,9 thousand people 811,8 thousand people recovered.
Coronavirus infection is transmitted via small droplets that are emitted from the nose or mouth of the patient and settle on surrounding objects. The who recommends that you stay at least four feet away from infected people, regularly wash or decontaminate hands and don’t touch your mouth, nose and eyes.